Browsed by
Category: Energy and Commerce Committee

Science Policy Weekly Roundup: January 12, 2018   ?>

Science Policy Weekly Roundup: January 12, 2018  

  Government shutdown threat grows as Democrats and conservatives dig in The continuing resolution funding the federal government expires on Jan. 19, and negotiations for a bipartisan budget deal remain difficult. Democrats are tying budget negotiations to an immigration deal that would provide protections to recipients of the Deferred Action for Childhood Arrivals, or DACA, program. Passing another continuing resolution to temporarily fund the government for another month also may prove challenging. These temporary funding strategies prevent federal agencies like…

Read More Read More

Science Policy Roundup: December 8, 2017 ?>

Science Policy Roundup: December 8, 2017

ASBMB members urge Congress to remove graduate student tax from the final tax reform effort So far, 1,013 ASBMB members have sent 3,106 letters to 369 members of Congress in a push to ensure that the repeal of the graduate student tuition tax waiver does not make it onto the final tax reform bill. The bill is in conference committee, as the House and Senate negotiators are amending the legislation to ensure passage through both chambers. Take action here. Episode…

Read More Read More

The U.S. House health subcommittee receives an update on the impact of the 21st Century Cures Act ?>

The U.S. House health subcommittee receives an update on the impact of the 21st Century Cures Act

  The U.S. House Energy and Commerce Committee’s health subcommittee held a hearing this week to receive updates on the implementation of the 21st Century Cures. Francis S. Collins, director of the National Institutes of Health, and Scott Gottlieb, commissioner of the Food and Drug Administration, provided testimony and updates from their agencies. Highlights from the hearing are below. You can watch a recording here. We’re including timestamps on our highlights for your quick reference. 17:17 – U.S. Rep. Michael…

Read More Read More

Senate appropriations bills provide a boost to DOE’s office of Science and a cut to NSF in 2018 ?>

Senate appropriations bills provide a boost to DOE’s office of Science and a cut to NSF in 2018

  The Senate Appropriations Committee has approved two draft funding bills for fiscal 2018 that conflict with appropriation bills proposed by the House earlier this month.  The House Appropriations Committee proposed flat funding for the National Science Foundation research programs and Department of Energy’s Office of Science. The Senate, however, is seeking to provide a slight cut and increase, respectively. Under the budgets put forth by the Senate Appropriations Committee, the NSF would receive $7.3 billion and the Department of…

Read More Read More

Floor debate begins on HR 6 – 21st Century Cures ?>

Floor debate begins on HR 6 – 21st Century Cures

With debate starting – here’s a summary of where the legislation stands as it heads to the House floor. If you’ve been following the progress of H.R. 6, the 21st Century Cures Act, you’ve seen momentum for the bill grow, and may have felt (like we did) that its passage is a foregone conclusion. It was only a few weeks ago that we reported on the House Energy and Commerce Committee’s bipartisan and unanimous passage of the bill out of…

Read More Read More

21st Century Cures Act passes committee ?>

21st Century Cures Act passes committee

Today, the U.S. House Energy and Commerce committee voted unanimously in favor of the 21st Century Cures Act, formally known as H.R. 6. Work on this legislation began over a year ago with the goal of speeding discovery, development and delivery of therapies and cures to patients. Should H.R. 6 become law, it would make important changes to the National Institutes of Health, the Food and Drug Administration and other federal agencies working on healthcare issues. The 21st Century Cures…

Read More Read More

Progress on the 21st Century Cures Act ?>

Progress on the 21st Century Cures Act

On Thursday, the U.S. House Energy and Commerce committee held a legislative hearing on the draft 21st Century Cures Act. This hearing was a forum for legislators to ask questions of Dr. Kathy Hudson, of the National Institutes of Health, and two Food and Drug Administration officials about provisions in the draft bill.

Another try for 21st Century Cures ?>

Another try for 21st Century Cures

Today, the U.S. House Energy and Commerce committee released a second draft of the 21st Century Cures Act. The original draft was released in January and contained several questionable provisions regarding the National Institutes of Health.

21st Century Cures Act introduced ?>

21st Century Cures Act introduced

Throughout most of 2014, the U.S. House Energy and Commerce committee was engaged in the 21st Century Cures initiative. The goal of this initiative was to speed the discovery, development and delivery of therapies for the myriad illnesses that affect Americans today.